Related Experiment Video
Updated: Jul 17, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Bronchopulmonary dysplasia: an update
Anita Bhandari1, Vineet Bhandari
1Division of Pediatric Pulmonology, Connecticut Children's Medical Center, Hartford, CT, USA.
Insights
Bronchopulmonary dysplasia (BPD), a chronic lung disease in premature infants, has evolving management strategies. Research explores novel treatments and genetic factors to improve outcomes and reduce long-term complications.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Developmental Biology
Background:
- Bronchopulmonary dysplasia (BPD) is a significant complication of prematurity, characterized by chronic lung injury.
- The definition, pathology, and management of BPD have evolved considerably over the last 40 years.
- Infants with BPD often experience persistent pulmonary and neurodevelopmental issues.
Purpose of the Study:
- To review the evolving landscape of Bronchopulmonary dysplasia (BPD) management.
- To highlight novel therapeutic strategies and the importance of nutrition and infection prophylaxis.
- To emphasize the potential of genetic research in advancing BPD prevention and treatment.
Main Methods:
- Literature review of changes in BPD definition, pathology, and management over four decades.
- Discussion of current and emerging treatment modalities, including non-invasive ventilation and novel therapies.
- Emphasis on nutritional support and viral infection prophylaxis.
Main Results:
- Management strategies for both acute and later stages of BPD continue to advance.
- Novel approaches such as non-invasive ventilation, recombinant human SOD, CC10, and inhaled NO are under investigation.
- Nutritional adequacy and viral infection prophylaxis are crucial for lung repair and reduced rehospitalization.
Conclusions:
- Despite advances, infants with BPD face ongoing pulmonary and neurodevelopmental challenges.
- Continued research into genetic contributions is essential for developing improved preventive and therapeutic strategies for BPD.
- Optimizing lung growth and repair through nutrition and preventing infections remains vital.
Abstract:
Bronchopulmonary dysplasia (BPD) is a chronic lung disease associated with premature birth and characterized by early lung injury. Over the past 4 decades, there have been significant changes in its definition, pathology and radiological findings as well as management of BPD. Management of the acute phase and later stages of this lung disease continue to evolve. Use of non-invasive ventilatory techniques, recombinant human SOD and CC10 and inhaled NO are some novel approaches that are being studied. Adequate nutrition is vital to optimize lung growth and repair. The widely accepted practice of prophylaxis against viral infections has markedly decreased the rates of rehospitalization. Infants with BPD, however, continue to have significant pulmonary and neurodevelopmental sequelae. Unraveling the genetic contribution to BPD will potentially pave the way to improved preventive and therapeutic approaches.
Related Concept Videos
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...